Robaxisal

Mucocutaneous Lymph Node Syndrome, Mortality, Atrial Fibrillation + 94 more

Treatment

21 FDA approvals

20 Active Studies for Robaxisal

What is Robaxisal

Acetylsalicylic acid

The Generic name of this drug

Treatment Summary

Acetylsalicylic acid, more commonly known as Aspirin, is a drug used to reduce pain and fever. It is a non-selective cyclooxygenase (COX) inhibitor and is available in various doses and forms, such as chewable tablets, suppositories, and extended release formulations. Long-term use of Acetylsalicylic acid may also lower the risk of certain types of cancer. Aspirin is very dangerous for young children and should always be kept out of reach.

Percodan

is the brand name

Robaxisal Overview & Background

Brand Name

Generic Name

First FDA Approval

How many FDA approvals?

Percodan

Acetylsalicylic acid

1950

226

Approved as Treatment by the FDA

Acetylsalicylic acid, otherwise known as Percodan, is approved by the FDA for 21 uses like acute Inflammation and Tension Headache .

acute Inflammation

Tension Headache

Used to treat Tension Headache in combination with Butalbital

Inflammation

Inflammation

Transient Ischemic Attack

Used to treat previous transient ischemic attack in combination with Dipyridamole

Stroke

Used to treat previous stroke in combination with Dipyridamole

Chronic Pain

Used to treat Pain in combination with Oxycodone

Secondary Prevention

Musculoskeletal Diseases

Used to treat Musculoskeletal Disorders in combination with Codeine

Spasm

Used to treat Muscle Contraction in combination with Butalbital

Musculoskeletal Disorders

Used to treat Musculoskeletal Disorders in combination with Codeine

Muscle Contraction

Used to treat Muscle Contraction in combination with Butalbital

Inflammation

Pain

Used to treat Pain in combination with Oxycodone

Pain

Used to treat moderate Pain in combination with Codeine

Fever

Used to treat Fever in combination with Caffeine

Stroke

Used to treat Cerebrovascular Accident in combination with Dipyridamole

Tension-Type Headache

Used to treat Tension Headache in combination with Butalbital

Pain

Used to treat Severe Pain in combination with Codeine

Inflammation

Cerebral Infarction

Effectiveness

How Robaxisal Affects Patients

Acetylsalicylic acid (ASA) helps to reduce pain, fever, and the risk of heart attack or stroke by blocking the production of prostaglandins and thromboxane A2. Prostaglandins are substances that cause pain and inflammation, while thromboxane A2 is responsible for clot formation. Studies have also suggested that taking ASA for a long period of time may help to reduce the risk of certain types of cancers, such as stomach, colorectal, pancreatic, and liver cancer. More research is needed to confirm this.

How Robaxisal works in the body

Acetylsalicylic acid (ASA) prevents pain-causing molecules from forming. It does this by blocking an enzyme called cyclooxygenase-1 (COX-1). This enzyme helps turn a molecule called arachidonic acid into pain-causing molecules, so blocking it stops the production of those molecules. ASA is also able to block cyclooxygenase-2 (COX-2), but it has to be in higher doses to do this. ASA can also prevent blood clots by blocking the formation of a molecule called thromboxane A2, which helps make platelets

When to interrupt dosage

The proposed dosage of Robaxisal is contingent upon the recognized condition, including Juvenile arthritis, Transient Ischemic Attack and Unstable Angina Pectoris. The amount additionally relies on the technique of delivery (e.g. Paste - Dental or Kit; Liquid; Ointment; Swab; Tablet - Oral; Topical) featured in the table beneath.

Condition

Dosage

Administration

Inflammation

, 25.0 mg, 500.0 mg, 325.0 mg, 250.0 mg, 81.0 mg, 400.0 mg, 162.0 mg, 300.0 mg, 600.0 mg, 325000.0 mg, 770.0 mg, 8.1 mg/mg, 3.25 mg/mg, 0.325 mg, 0.81 mg, 0.5 mg, 356.4 mg, 650.0 mg, 162.5 mg, 845.0 mg, 1000.0 mg, 520.0 mg, 385.0 mg, 80.0 mg, 975.0 mg, 330.0 mg, 350.0 mg, 375.0 mg, 8.33 %, 150.0 mg, 2.2 mg/mg, 227.0 mg, 75.0 mg, 100.0 mg, 200.0 mg, 262.5 mg, 230.0 mg, 421.0 mg, 210.0 mg, 742.0 mg, 410.0 mg, 260.0 mg, 360.0 mg, 850.0 mg, 425.0 mg, 180.0 mg, 0.162 mg, 6.0 mg, 60.0 mg/mL

, Capsule, Oral, Capsule - Oral, Tablet, film coated, Tablet, film coated - Oral, Tablet, coated - Oral, Tablet, coated, Tablet, Tablet - Oral, Tablet, effervescent, Tablet, effervescent - Oral, Tablet, chewable, Tablet, chewable - Oral, Powder, Powder - Oral, Suppository, Suppository - Rectal, Rectal, Kit, Tablet, multilayer - Oral, Tablet, multilayer, Tablet, delayed release, Tablet, extended release - Oral, Tablet, extended release, Capsule, extended release, Capsule, extended release - Oral, Strip - Oral, Capsule, coated - Oral, Capsule, coated, Capsule, gelatin coated, Capsule, gelatin coated - Oral, Tablet, delayed release - Oral, Tablet, orally disintegrating - Oral, Tablet, orally disintegrating, Strip, Tablet, delayed release; Tablet, extended release - Oral, Tablet, delayed release; Tablet, extended release, Gum, chewing, Gum, chewing - Oral, Kit; Tablet; Tablet, delayed release, Kit; Tablet; Tablet, delayed release - Oral, Kit; Tablet, delayed release; Tablet, extended release - Oral, Kit; Tablet, delayed release; Tablet, extended release, Paste - Dental, Dental, Paste, Granule, effervescent, Granule, effervescent - Oral, Topical, Granule, Granule - Oral, Oral; Topical, Kit - Oral; Topical, Tablet, Delayed Release - Oral, Tablet, Delayed Release, Capsule, Delayed Release - Oral, Kit - Topical, Capsule, Delayed Release, Kit - Oral, Kit - Ophthalmic; Oral; Topical, Ophthalmic; Oral; Topical, Ophthalmic; Oral; Respiratory (inhalation); Topical, Kit - Ophthalmic; Oral; Respiratory (inhalation); Topical, Lozenge, Lozenge - Oral, Spray, Kit - Oral; Respiratory (inhalation); Topical, Oral; Respiratory (inhalation); Topical, Tablet, film coated - Topical, Spray - Oral, Irrigation; Oral; Respiratory (inhalation); Topical, Kit - Irrigation; Oral; Respiratory (inhalation); Topical, Kit - Irrigation; Ophthalmic; Oral; Respiratory (inhalation); Topical, Irrigation; Ophthalmic; Oral; Respiratory (inhalation); Topical

Sprains and Strains

, 25.0 mg, 500.0 mg, 325.0 mg, 250.0 mg, 81.0 mg, 400.0 mg, 162.0 mg, 300.0 mg, 600.0 mg, 325000.0 mg, 770.0 mg, 8.1 mg/mg, 3.25 mg/mg, 0.325 mg, 0.81 mg, 0.5 mg, 356.4 mg, 650.0 mg, 162.5 mg, 845.0 mg, 1000.0 mg, 520.0 mg, 385.0 mg, 80.0 mg, 975.0 mg, 330.0 mg, 350.0 mg, 375.0 mg, 8.33 %, 150.0 mg, 2.2 mg/mg, 227.0 mg, 75.0 mg, 100.0 mg, 200.0 mg, 262.5 mg, 230.0 mg, 421.0 mg, 210.0 mg, 742.0 mg, 410.0 mg, 260.0 mg, 360.0 mg, 850.0 mg, 425.0 mg, 180.0 mg, 0.162 mg, 6.0 mg, 60.0 mg/mL

, Capsule, Oral, Capsule - Oral, Tablet, film coated, Tablet, film coated - Oral, Tablet, coated - Oral, Tablet, coated, Tablet, Tablet - Oral, Tablet, effervescent, Tablet, effervescent - Oral, Tablet, chewable, Tablet, chewable - Oral, Powder, Powder - Oral, Suppository, Suppository - Rectal, Rectal, Kit, Tablet, multilayer - Oral, Tablet, multilayer, Tablet, delayed release, Tablet, extended release - Oral, Tablet, extended release, Capsule, extended release, Capsule, extended release - Oral, Strip - Oral, Capsule, coated - Oral, Capsule, coated, Capsule, gelatin coated, Capsule, gelatin coated - Oral, Tablet, delayed release - Oral, Tablet, orally disintegrating - Oral, Tablet, orally disintegrating, Strip, Tablet, delayed release; Tablet, extended release - Oral, Tablet, delayed release; Tablet, extended release, Gum, chewing, Gum, chewing - Oral, Kit; Tablet; Tablet, delayed release, Kit; Tablet; Tablet, delayed release - Oral, Kit; Tablet, delayed release; Tablet, extended release - Oral, Kit; Tablet, delayed release; Tablet, extended release, Paste - Dental, Dental, Paste, Granule, effervescent, Granule, effervescent - Oral, Topical, Granule, Granule - Oral, Oral; Topical, Kit - Oral; Topical, Tablet, Delayed Release - Oral, Tablet, Delayed Release, Capsule, Delayed Release - Oral, Kit - Topical, Capsule, Delayed Release, Kit - Oral, Kit - Ophthalmic; Oral; Topical, Ophthalmic; Oral; Topical, Ophthalmic; Oral; Respiratory (inhalation); Topical, Kit - Ophthalmic; Oral; Respiratory (inhalation); Topical, Lozenge, Lozenge - Oral, Spray, Kit - Oral; Respiratory (inhalation); Topical, Oral; Respiratory (inhalation); Topical, Tablet, film coated - Topical, Spray - Oral, Irrigation; Oral; Respiratory (inhalation); Topical, Kit - Irrigation; Oral; Respiratory (inhalation); Topical, Kit - Irrigation; Ophthalmic; Oral; Respiratory (inhalation); Topical, Irrigation; Ophthalmic; Oral; Respiratory (inhalation); Topical

Cardiovascular Mortality

, 25.0 mg, 500.0 mg, 325.0 mg, 250.0 mg, 81.0 mg, 400.0 mg, 162.0 mg, 300.0 mg, 600.0 mg, 325000.0 mg, 770.0 mg, 8.1 mg/mg, 3.25 mg/mg, 0.325 mg, 0.81 mg, 0.5 mg, 356.4 mg, 650.0 mg, 162.5 mg, 845.0 mg, 1000.0 mg, 520.0 mg, 385.0 mg, 80.0 mg, 975.0 mg, 330.0 mg, 350.0 mg, 375.0 mg, 8.33 %, 150.0 mg, 2.2 mg/mg, 227.0 mg, 75.0 mg, 100.0 mg, 200.0 mg, 262.5 mg, 230.0 mg, 421.0 mg, 210.0 mg, 742.0 mg, 410.0 mg, 260.0 mg, 360.0 mg, 850.0 mg, 425.0 mg, 180.0 mg, 0.162 mg, 6.0 mg, 60.0 mg/mL

, Capsule, Oral, Capsule - Oral, Tablet, film coated, Tablet, film coated - Oral, Tablet, coated - Oral, Tablet, coated, Tablet, Tablet - Oral, Tablet, effervescent, Tablet, effervescent - Oral, Tablet, chewable, Tablet, chewable - Oral, Powder, Powder - Oral, Suppository, Suppository - Rectal, Rectal, Kit, Tablet, multilayer - Oral, Tablet, multilayer, Tablet, delayed release, Tablet, extended release - Oral, Tablet, extended release, Capsule, extended release, Capsule, extended release - Oral, Strip - Oral, Capsule, coated - Oral, Capsule, coated, Capsule, gelatin coated, Capsule, gelatin coated - Oral, Tablet, delayed release - Oral, Tablet, orally disintegrating - Oral, Tablet, orally disintegrating, Strip, Tablet, delayed release; Tablet, extended release - Oral, Tablet, delayed release; Tablet, extended release, Gum, chewing, Gum, chewing - Oral, Kit; Tablet; Tablet, delayed release, Kit; Tablet; Tablet, delayed release - Oral, Kit; Tablet, delayed release; Tablet, extended release - Oral, Kit; Tablet, delayed release; Tablet, extended release, Paste - Dental, Dental, Paste, Granule, effervescent, Granule, effervescent - Oral, Topical, Granule, Granule - Oral, Oral; Topical, Kit - Oral; Topical, Tablet, Delayed Release - Oral, Tablet, Delayed Release, Capsule, Delayed Release - Oral, Kit - Topical, Capsule, Delayed Release, Kit - Oral, Kit - Ophthalmic; Oral; Topical, Ophthalmic; Oral; Topical, Ophthalmic; Oral; Respiratory (inhalation); Topical, Kit - Ophthalmic; Oral; Respiratory (inhalation); Topical, Lozenge, Lozenge - Oral, Spray, Kit - Oral; Respiratory (inhalation); Topical, Oral; Respiratory (inhalation); Topical, Tablet, film coated - Topical, Spray - Oral, Irrigation; Oral; Respiratory (inhalation); Topical, Kit - Irrigation; Oral; Respiratory (inhalation); Topical, Kit - Irrigation; Ophthalmic; Oral; Respiratory (inhalation); Topical, Irrigation; Ophthalmic; Oral; Respiratory (inhalation); Topical

Circulation, Extracorporeal

, 25.0 mg, 500.0 mg, 325.0 mg, 250.0 mg, 81.0 mg, 400.0 mg, 162.0 mg, 300.0 mg, 600.0 mg, 325000.0 mg, 770.0 mg, 8.1 mg/mg, 3.25 mg/mg, 0.325 mg, 0.81 mg, 0.5 mg, 356.4 mg, 650.0 mg, 162.5 mg, 845.0 mg, 1000.0 mg, 520.0 mg, 385.0 mg, 80.0 mg, 975.0 mg, 330.0 mg, 350.0 mg, 375.0 mg, 8.33 %, 150.0 mg, 2.2 mg/mg, 227.0 mg, 75.0 mg, 100.0 mg, 200.0 mg, 262.5 mg, 230.0 mg, 421.0 mg, 210.0 mg, 742.0 mg, 410.0 mg, 260.0 mg, 360.0 mg, 850.0 mg, 425.0 mg, 180.0 mg, 0.162 mg, 6.0 mg, 60.0 mg/mL

, Capsule, Oral, Capsule - Oral, Tablet, film coated, Tablet, film coated - Oral, Tablet, coated - Oral, Tablet, coated, Tablet, Tablet - Oral, Tablet, effervescent, Tablet, effervescent - Oral, Tablet, chewable, Tablet, chewable - Oral, Powder, Powder - Oral, Suppository, Suppository - Rectal, Rectal, Kit, Tablet, multilayer - Oral, Tablet, multilayer, Tablet, delayed release, Tablet, extended release - Oral, Tablet, extended release, Capsule, extended release, Capsule, extended release - Oral, Strip - Oral, Capsule, coated - Oral, Capsule, coated, Capsule, gelatin coated, Capsule, gelatin coated - Oral, Tablet, delayed release - Oral, Tablet, orally disintegrating - Oral, Tablet, orally disintegrating, Strip, Tablet, delayed release; Tablet, extended release - Oral, Tablet, delayed release; Tablet, extended release, Gum, chewing, Gum, chewing - Oral, Kit; Tablet; Tablet, delayed release, Kit; Tablet; Tablet, delayed release - Oral, Kit; Tablet, delayed release; Tablet, extended release - Oral, Kit; Tablet, delayed release; Tablet, extended release, Paste - Dental, Dental, Paste, Granule, effervescent, Granule, effervescent - Oral, Topical, Granule, Granule - Oral, Oral; Topical, Kit - Oral; Topical, Tablet, Delayed Release - Oral, Tablet, Delayed Release, Capsule, Delayed Release - Oral, Kit - Topical, Capsule, Delayed Release, Kit - Oral, Kit - Ophthalmic; Oral; Topical, Ophthalmic; Oral; Topical, Ophthalmic; Oral; Respiratory (inhalation); Topical, Kit - Ophthalmic; Oral; Respiratory (inhalation); Topical, Lozenge, Lozenge - Oral, Spray, Kit - Oral; Respiratory (inhalation); Topical, Oral; Respiratory (inhalation); Topical, Tablet, film coated - Topical, Spray - Oral, Irrigation; Oral; Respiratory (inhalation); Topical, Kit - Irrigation; Oral; Respiratory (inhalation); Topical, Kit - Irrigation; Ophthalmic; Oral; Respiratory (inhalation); Topical, Irrigation; Ophthalmic; Oral; Respiratory (inhalation); Topical

Neck Pain

, 25.0 mg, 500.0 mg, 325.0 mg, 250.0 mg, 81.0 mg, 400.0 mg, 162.0 mg, 300.0 mg, 600.0 mg, 325000.0 mg, 770.0 mg, 8.1 mg/mg, 3.25 mg/mg, 0.325 mg, 0.81 mg, 0.5 mg, 356.4 mg, 650.0 mg, 162.5 mg, 845.0 mg, 1000.0 mg, 520.0 mg, 385.0 mg, 80.0 mg, 975.0 mg, 330.0 mg, 350.0 mg, 375.0 mg, 8.33 %, 150.0 mg, 2.2 mg/mg, 227.0 mg, 75.0 mg, 100.0 mg, 200.0 mg, 262.5 mg, 230.0 mg, 421.0 mg, 210.0 mg, 742.0 mg, 410.0 mg, 260.0 mg, 360.0 mg, 850.0 mg, 425.0 mg, 180.0 mg, 0.162 mg, 6.0 mg, 60.0 mg/mL

, Capsule, Oral, Capsule - Oral, Tablet, film coated, Tablet, film coated - Oral, Tablet, coated - Oral, Tablet, coated, Tablet, Tablet - Oral, Tablet, effervescent, Tablet, effervescent - Oral, Tablet, chewable, Tablet, chewable - Oral, Powder, Powder - Oral, Suppository, Suppository - Rectal, Rectal, Kit, Tablet, multilayer - Oral, Tablet, multilayer, Tablet, delayed release, Tablet, extended release - Oral, Tablet, extended release, Capsule, extended release, Capsule, extended release - Oral, Strip - Oral, Capsule, coated - Oral, Capsule, coated, Capsule, gelatin coated, Capsule, gelatin coated - Oral, Tablet, delayed release - Oral, Tablet, orally disintegrating - Oral, Tablet, orally disintegrating, Strip, Tablet, delayed release; Tablet, extended release - Oral, Tablet, delayed release; Tablet, extended release, Gum, chewing, Gum, chewing - Oral, Kit; Tablet; Tablet, delayed release, Kit; Tablet; Tablet, delayed release - Oral, Kit; Tablet, delayed release; Tablet, extended release - Oral, Kit; Tablet, delayed release; Tablet, extended release, Paste - Dental, Dental, Paste, Granule, effervescent, Granule, effervescent - Oral, Topical, Granule, Granule - Oral, Oral; Topical, Kit - Oral; Topical, Tablet, Delayed Release - Oral, Tablet, Delayed Release, Capsule, Delayed Release - Oral, Kit - Topical, Capsule, Delayed Release, Kit - Oral, Kit - Ophthalmic; Oral; Topical, Ophthalmic; Oral; Topical, Ophthalmic; Oral; Respiratory (inhalation); Topical, Kit - Ophthalmic; Oral; Respiratory (inhalation); Topical, Lozenge, Lozenge - Oral, Spray, Kit - Oral; Respiratory (inhalation); Topical, Oral; Respiratory (inhalation); Topical, Tablet, film coated - Topical, Spray - Oral, Irrigation; Oral; Respiratory (inhalation); Topical, Kit - Irrigation; Oral; Respiratory (inhalation); Topical, Kit - Irrigation; Ophthalmic; Oral; Respiratory (inhalation); Topical, Irrigation; Ophthalmic; Oral; Respiratory (inhalation); Topical

Hyperacusis

, 25.0 mg, 500.0 mg, 325.0 mg, 250.0 mg, 81.0 mg, 400.0 mg, 162.0 mg, 300.0 mg, 600.0 mg, 325000.0 mg, 770.0 mg, 8.1 mg/mg, 3.25 mg/mg, 0.325 mg, 0.81 mg, 0.5 mg, 356.4 mg, 650.0 mg, 162.5 mg, 845.0 mg, 1000.0 mg, 520.0 mg, 385.0 mg, 80.0 mg, 975.0 mg, 330.0 mg, 350.0 mg, 375.0 mg, 8.33 %, 150.0 mg, 2.2 mg/mg, 227.0 mg, 75.0 mg, 100.0 mg, 200.0 mg, 262.5 mg, 230.0 mg, 421.0 mg, 210.0 mg, 742.0 mg, 410.0 mg, 260.0 mg, 360.0 mg, 850.0 mg, 425.0 mg, 180.0 mg, 0.162 mg, 6.0 mg, 60.0 mg/mL

, Capsule, Oral, Capsule - Oral, Tablet, film coated, Tablet, film coated - Oral, Tablet, coated - Oral, Tablet, coated, Tablet, Tablet - Oral, Tablet, effervescent, Tablet, effervescent - Oral, Tablet, chewable, Tablet, chewable - Oral, Powder, Powder - Oral, Suppository, Suppository - Rectal, Rectal, Kit, Tablet, multilayer - Oral, Tablet, multilayer, Tablet, delayed release, Tablet, extended release - Oral, Tablet, extended release, Capsule, extended release, Capsule, extended release - Oral, Strip - Oral, Capsule, coated - Oral, Capsule, coated, Capsule, gelatin coated, Capsule, gelatin coated - Oral, Tablet, delayed release - Oral, Tablet, orally disintegrating - Oral, Tablet, orally disintegrating, Strip, Tablet, delayed release; Tablet, extended release - Oral, Tablet, delayed release; Tablet, extended release, Gum, chewing, Gum, chewing - Oral, Kit; Tablet; Tablet, delayed release, Kit; Tablet; Tablet, delayed release - Oral, Kit; Tablet, delayed release; Tablet, extended release - Oral, Kit; Tablet, delayed release; Tablet, extended release, Paste - Dental, Dental, Paste, Granule, effervescent, Granule, effervescent - Oral, Topical, Granule, Granule - Oral, Oral; Topical, Kit - Oral; Topical, Tablet, Delayed Release - Oral, Tablet, Delayed Release, Capsule, Delayed Release - Oral, Kit - Topical, Capsule, Delayed Release, Kit - Oral, Kit - Ophthalmic; Oral; Topical, Ophthalmic; Oral; Topical, Ophthalmic; Oral; Respiratory (inhalation); Topical, Kit - Ophthalmic; Oral; Respiratory (inhalation); Topical, Lozenge, Lozenge - Oral, Spray, Kit - Oral; Respiratory (inhalation); Topical, Oral; Respiratory (inhalation); Topical, Tablet, film coated - Topical, Spray - Oral, Irrigation; Oral; Respiratory (inhalation); Topical, Kit - Irrigation; Oral; Respiratory (inhalation); Topical, Kit - Irrigation; Ophthalmic; Oral; Respiratory (inhalation); Topical, Irrigation; Ophthalmic; Oral; Respiratory (inhalation); Topical

Myocardial Infarction

, 25.0 mg, 500.0 mg, 325.0 mg, 250.0 mg, 81.0 mg, 400.0 mg, 162.0 mg, 300.0 mg, 600.0 mg, 325000.0 mg, 770.0 mg, 8.1 mg/mg, 3.25 mg/mg, 0.325 mg, 0.81 mg, 0.5 mg, 356.4 mg, 650.0 mg, 162.5 mg, 845.0 mg, 1000.0 mg, 520.0 mg, 385.0 mg, 80.0 mg, 975.0 mg, 330.0 mg, 350.0 mg, 375.0 mg, 8.33 %, 150.0 mg, 2.2 mg/mg, 227.0 mg, 75.0 mg, 100.0 mg, 200.0 mg, 262.5 mg, 230.0 mg, 421.0 mg, 210.0 mg, 742.0 mg, 410.0 mg, 260.0 mg, 360.0 mg, 850.0 mg, 425.0 mg, 180.0 mg, 0.162 mg, 6.0 mg, 60.0 mg/mL

, Capsule, Oral, Capsule - Oral, Tablet, film coated, Tablet, film coated - Oral, Tablet, coated - Oral, Tablet, coated, Tablet, Tablet - Oral, Tablet, effervescent, Tablet, effervescent - Oral, Tablet, chewable, Tablet, chewable - Oral, Powder, Powder - Oral, Suppository, Suppository - Rectal, Rectal, Kit, Tablet, multilayer - Oral, Tablet, multilayer, Tablet, delayed release, Tablet, extended release - Oral, Tablet, extended release, Capsule, extended release, Capsule, extended release - Oral, Strip - Oral, Capsule, coated - Oral, Capsule, coated, Capsule, gelatin coated, Capsule, gelatin coated - Oral, Tablet, delayed release - Oral, Tablet, orally disintegrating - Oral, Tablet, orally disintegrating, Strip, Tablet, delayed release; Tablet, extended release - Oral, Tablet, delayed release; Tablet, extended release, Gum, chewing, Gum, chewing - Oral, Kit; Tablet; Tablet, delayed release, Kit; Tablet; Tablet, delayed release - Oral, Kit; Tablet, delayed release; Tablet, extended release - Oral, Kit; Tablet, delayed release; Tablet, extended release, Paste - Dental, Dental, Paste, Granule, effervescent, Granule, effervescent - Oral, Topical, Granule, Granule - Oral, Oral; Topical, Kit - Oral; Topical, Tablet, Delayed Release - Oral, Tablet, Delayed Release, Capsule, Delayed Release - Oral, Kit - Topical, Capsule, Delayed Release, Kit - Oral, Kit - Ophthalmic; Oral; Topical, Ophthalmic; Oral; Topical, Ophthalmic; Oral; Respiratory (inhalation); Topical, Kit - Ophthalmic; Oral; Respiratory (inhalation); Topical, Lozenge, Lozenge - Oral, Spray, Kit - Oral; Respiratory (inhalation); Topical, Oral; Respiratory (inhalation); Topical, Tablet, film coated - Topical, Spray - Oral, Irrigation; Oral; Respiratory (inhalation); Topical, Kit - Irrigation; Oral; Respiratory (inhalation); Topical, Kit - Irrigation; Ophthalmic; Oral; Respiratory (inhalation); Topical, Irrigation; Ophthalmic; Oral; Respiratory (inhalation); Topical

Silicone rubber arteriovenous cannula

, 25.0 mg, 500.0 mg, 325.0 mg, 250.0 mg, 81.0 mg, 400.0 mg, 162.0 mg, 300.0 mg, 600.0 mg, 325000.0 mg, 770.0 mg, 8.1 mg/mg, 3.25 mg/mg, 0.325 mg, 0.81 mg, 0.5 mg, 356.4 mg, 650.0 mg, 162.5 mg, 845.0 mg, 1000.0 mg, 520.0 mg, 385.0 mg, 80.0 mg, 975.0 mg, 330.0 mg, 350.0 mg, 375.0 mg, 8.33 %, 150.0 mg, 2.2 mg/mg, 227.0 mg, 75.0 mg, 100.0 mg, 200.0 mg, 262.5 mg, 230.0 mg, 421.0 mg, 210.0 mg, 742.0 mg, 410.0 mg, 260.0 mg, 360.0 mg, 850.0 mg, 425.0 mg, 180.0 mg, 0.162 mg, 6.0 mg, 60.0 mg/mL

, Capsule, Oral, Capsule - Oral, Tablet, film coated, Tablet, film coated - Oral, Tablet, coated - Oral, Tablet, coated, Tablet, Tablet - Oral, Tablet, effervescent, Tablet, effervescent - Oral, Tablet, chewable, Tablet, chewable - Oral, Powder, Powder - Oral, Suppository, Suppository - Rectal, Rectal, Kit, Tablet, multilayer - Oral, Tablet, multilayer, Tablet, delayed release, Tablet, extended release - Oral, Tablet, extended release, Capsule, extended release, Capsule, extended release - Oral, Strip - Oral, Capsule, coated - Oral, Capsule, coated, Capsule, gelatin coated, Capsule, gelatin coated - Oral, Tablet, delayed release - Oral, Tablet, orally disintegrating - Oral, Tablet, orally disintegrating, Strip, Tablet, delayed release; Tablet, extended release - Oral, Tablet, delayed release; Tablet, extended release, Gum, chewing, Gum, chewing - Oral, Kit; Tablet; Tablet, delayed release, Kit; Tablet; Tablet, delayed release - Oral, Kit; Tablet, delayed release; Tablet, extended release - Oral, Kit; Tablet, delayed release; Tablet, extended release, Paste - Dental, Dental, Paste, Granule, effervescent, Granule, effervescent - Oral, Topical, Granule, Granule - Oral, Oral; Topical, Kit - Oral; Topical, Tablet, Delayed Release - Oral, Tablet, Delayed Release, Capsule, Delayed Release - Oral, Kit - Topical, Capsule, Delayed Release, Kit - Oral, Kit - Ophthalmic; Oral; Topical, Ophthalmic; Oral; Topical, Ophthalmic; Oral; Respiratory (inhalation); Topical, Kit - Ophthalmic; Oral; Respiratory (inhalation); Topical, Lozenge, Lozenge - Oral, Spray, Kit - Oral; Respiratory (inhalation); Topical, Oral; Respiratory (inhalation); Topical, Tablet, film coated - Topical, Spray - Oral, Irrigation; Oral; Respiratory (inhalation); Topical, Kit - Irrigation; Oral; Respiratory (inhalation); Topical, Kit - Irrigation; Ophthalmic; Oral; Respiratory (inhalation); Topical, Irrigation; Ophthalmic; Oral; Respiratory (inhalation); Topical

Carotid Stenosis

, 25.0 mg, 500.0 mg, 325.0 mg, 250.0 mg, 81.0 mg, 400.0 mg, 162.0 mg, 300.0 mg, 600.0 mg, 325000.0 mg, 770.0 mg, 8.1 mg/mg, 3.25 mg/mg, 0.325 mg, 0.81 mg, 0.5 mg, 356.4 mg, 650.0 mg, 162.5 mg, 845.0 mg, 1000.0 mg, 520.0 mg, 385.0 mg, 80.0 mg, 975.0 mg, 330.0 mg, 350.0 mg, 375.0 mg, 8.33 %, 150.0 mg, 2.2 mg/mg, 227.0 mg, 75.0 mg, 100.0 mg, 200.0 mg, 262.5 mg, 230.0 mg, 421.0 mg, 210.0 mg, 742.0 mg, 410.0 mg, 260.0 mg, 360.0 mg, 850.0 mg, 425.0 mg, 180.0 mg, 0.162 mg, 6.0 mg, 60.0 mg/mL

, Capsule, Oral, Capsule - Oral, Tablet, film coated, Tablet, film coated - Oral, Tablet, coated - Oral, Tablet, coated, Tablet, Tablet - Oral, Tablet, effervescent, Tablet, effervescent - Oral, Tablet, chewable, Tablet, chewable - Oral, Powder, Powder - Oral, Suppository, Suppository - Rectal, Rectal, Kit, Tablet, multilayer - Oral, Tablet, multilayer, Tablet, delayed release, Tablet, extended release - Oral, Tablet, extended release, Capsule, extended release, Capsule, extended release - Oral, Strip - Oral, Capsule, coated - Oral, Capsule, coated, Capsule, gelatin coated, Capsule, gelatin coated - Oral, Tablet, delayed release - Oral, Tablet, orally disintegrating - Oral, Tablet, orally disintegrating, Strip, Tablet, delayed release; Tablet, extended release - Oral, Tablet, delayed release; Tablet, extended release, Gum, chewing, Gum, chewing - Oral, Kit; Tablet; Tablet, delayed release, Kit; Tablet; Tablet, delayed release - Oral, Kit; Tablet, delayed release; Tablet, extended release - Oral, Kit; Tablet, delayed release; Tablet, extended release, Paste - Dental, Dental, Paste, Granule, effervescent, Granule, effervescent - Oral, Topical, Granule, Granule - Oral, Oral; Topical, Kit - Oral; Topical, Tablet, Delayed Release - Oral, Tablet, Delayed Release, Capsule, Delayed Release - Oral, Kit - Topical, Capsule, Delayed Release, Kit - Oral, Kit - Ophthalmic; Oral; Topical, Ophthalmic; Oral; Topical, Ophthalmic; Oral; Respiratory (inhalation); Topical, Kit - Ophthalmic; Oral; Respiratory (inhalation); Topical, Lozenge, Lozenge - Oral, Spray, Kit - Oral; Respiratory (inhalation); Topical, Oral; Respiratory (inhalation); Topical, Tablet, film coated - Topical, Spray - Oral, Irrigation; Oral; Respiratory (inhalation); Topical, Kit - Irrigation; Oral; Respiratory (inhalation); Topical, Kit - Irrigation; Ophthalmic; Oral; Respiratory (inhalation); Topical, Irrigation; Ophthalmic; Oral; Respiratory (inhalation); Topical

Generalized Anxiety Disorder

, 25.0 mg, 500.0 mg, 325.0 mg, 250.0 mg, 81.0 mg, 400.0 mg, 162.0 mg, 300.0 mg, 600.0 mg, 325000.0 mg, 770.0 mg, 8.1 mg/mg, 3.25 mg/mg, 0.325 mg, 0.81 mg, 0.5 mg, 356.4 mg, 650.0 mg, 162.5 mg, 845.0 mg, 1000.0 mg, 520.0 mg, 385.0 mg, 80.0 mg, 975.0 mg, 330.0 mg, 350.0 mg, 375.0 mg, 8.33 %, 150.0 mg, 2.2 mg/mg, 227.0 mg, 75.0 mg, 100.0 mg, 200.0 mg, 262.5 mg, 230.0 mg, 421.0 mg, 210.0 mg, 742.0 mg, 410.0 mg, 260.0 mg, 360.0 mg, 850.0 mg, 425.0 mg, 180.0 mg, 0.162 mg, 6.0 mg, 60.0 mg/mL

, Capsule, Oral, Capsule - Oral, Tablet, film coated, Tablet, film coated - Oral, Tablet, coated - Oral, Tablet, coated, Tablet, Tablet - Oral, Tablet, effervescent, Tablet, effervescent - Oral, Tablet, chewable, Tablet, chewable - Oral, Powder, Powder - Oral, Suppository, Suppository - Rectal, Rectal, Kit, Tablet, multilayer - Oral, Tablet, multilayer, Tablet, delayed release, Tablet, extended release - Oral, Tablet, extended release, Capsule, extended release, Capsule, extended release - Oral, Strip - Oral, Capsule, coated - Oral, Capsule, coated, Capsule, gelatin coated, Capsule, gelatin coated - Oral, Tablet, delayed release - Oral, Tablet, orally disintegrating - Oral, Tablet, orally disintegrating, Strip, Tablet, delayed release; Tablet, extended release - Oral, Tablet, delayed release; Tablet, extended release, Gum, chewing, Gum, chewing - Oral, Kit; Tablet; Tablet, delayed release, Kit; Tablet; Tablet, delayed release - Oral, Kit; Tablet, delayed release; Tablet, extended release - Oral, Kit; Tablet, delayed release; Tablet, extended release, Paste - Dental, Dental, Paste, Granule, effervescent, Granule, effervescent - Oral, Topical, Granule, Granule - Oral, Oral; Topical, Kit - Oral; Topical, Tablet, Delayed Release - Oral, Tablet, Delayed Release, Capsule, Delayed Release - Oral, Kit - Topical, Capsule, Delayed Release, Kit - Oral, Kit - Ophthalmic; Oral; Topical, Ophthalmic; Oral; Topical, Ophthalmic; Oral; Respiratory (inhalation); Topical, Kit - Ophthalmic; Oral; Respiratory (inhalation); Topical, Lozenge, Lozenge - Oral, Spray, Kit - Oral; Respiratory (inhalation); Topical, Oral; Respiratory (inhalation); Topical, Tablet, film coated - Topical, Spray - Oral, Irrigation; Oral; Respiratory (inhalation); Topical, Kit - Irrigation; Oral; Respiratory (inhalation); Topical, Kit - Irrigation; Ophthalmic; Oral; Respiratory (inhalation); Topical, Irrigation; Ophthalmic; Oral; Respiratory (inhalation); Topical

Deep Vein Thrombosis (DVT)

, 25.0 mg, 500.0 mg, 325.0 mg, 250.0 mg, 81.0 mg, 400.0 mg, 162.0 mg, 300.0 mg, 600.0 mg, 325000.0 mg, 770.0 mg, 8.1 mg/mg, 3.25 mg/mg, 0.325 mg, 0.81 mg, 0.5 mg, 356.4 mg, 650.0 mg, 162.5 mg, 845.0 mg, 1000.0 mg, 520.0 mg, 385.0 mg, 80.0 mg, 975.0 mg, 330.0 mg, 350.0 mg, 375.0 mg, 8.33 %, 150.0 mg, 2.2 mg/mg, 227.0 mg, 75.0 mg, 100.0 mg, 200.0 mg, 262.5 mg, 230.0 mg, 421.0 mg, 210.0 mg, 742.0 mg, 410.0 mg, 260.0 mg, 360.0 mg, 850.0 mg, 425.0 mg, 180.0 mg, 0.162 mg, 6.0 mg, 60.0 mg/mL

, Capsule, Oral, Capsule - Oral, Tablet, film coated, Tablet, film coated - Oral, Tablet, coated - Oral, Tablet, coated, Tablet, Tablet - Oral, Tablet, effervescent, Tablet, effervescent - Oral, Tablet, chewable, Tablet, chewable - Oral, Powder, Powder - Oral, Suppository, Suppository - Rectal, Rectal, Kit, Tablet, multilayer - Oral, Tablet, multilayer, Tablet, delayed release, Tablet, extended release - Oral, Tablet, extended release, Capsule, extended release, Capsule, extended release - Oral, Strip - Oral, Capsule, coated - Oral, Capsule, coated, Capsule, gelatin coated, Capsule, gelatin coated - Oral, Tablet, delayed release - Oral, Tablet, orally disintegrating - Oral, Tablet, orally disintegrating, Strip, Tablet, delayed release; Tablet, extended release - Oral, Tablet, delayed release; Tablet, extended release, Gum, chewing, Gum, chewing - Oral, Kit; Tablet; Tablet, delayed release, Kit; Tablet; Tablet, delayed release - Oral, Kit; Tablet, delayed release; Tablet, extended release - Oral, Kit; Tablet, delayed release; Tablet, extended release, Paste - Dental, Dental, Paste, Granule, effervescent, Granule, effervescent - Oral, Topical, Granule, Granule - Oral, Oral; Topical, Kit - Oral; Topical, Tablet, Delayed Release - Oral, Tablet, Delayed Release, Capsule, Delayed Release - Oral, Kit - Topical, Capsule, Delayed Release, Kit - Oral, Kit - Ophthalmic; Oral; Topical, Ophthalmic; Oral; Topical, Ophthalmic; Oral; Respiratory (inhalation); Topical, Kit - Ophthalmic; Oral; Respiratory (inhalation); Topical, Lozenge, Lozenge - Oral, Spray, Kit - Oral; Respiratory (inhalation); Topical, Oral; Respiratory (inhalation); Topical, Tablet, film coated - Topical, Spray - Oral, Irrigation; Oral; Respiratory (inhalation); Topical, Kit - Irrigation; Oral; Respiratory (inhalation); Topical, Kit - Irrigation; Ophthalmic; Oral; Respiratory (inhalation); Topical, Irrigation; Ophthalmic; Oral; Respiratory (inhalation); Topical

Muscle Pain

, 25.0 mg, 500.0 mg, 325.0 mg, 250.0 mg, 81.0 mg, 400.0 mg, 162.0 mg, 300.0 mg, 600.0 mg, 325000.0 mg, 770.0 mg, 8.1 mg/mg, 3.25 mg/mg, 0.325 mg, 0.81 mg, 0.5 mg, 356.4 mg, 650.0 mg, 162.5 mg, 845.0 mg, 1000.0 mg, 520.0 mg, 385.0 mg, 80.0 mg, 975.0 mg, 330.0 mg, 350.0 mg, 375.0 mg, 8.33 %, 150.0 mg, 2.2 mg/mg, 227.0 mg, 75.0 mg, 100.0 mg, 200.0 mg, 262.5 mg, 230.0 mg, 421.0 mg, 210.0 mg, 742.0 mg, 410.0 mg, 260.0 mg, 360.0 mg, 850.0 mg, 425.0 mg, 180.0 mg, 0.162 mg, 6.0 mg, 60.0 mg/mL

, Capsule, Oral, Capsule - Oral, Tablet, film coated, Tablet, film coated - Oral, Tablet, coated - Oral, Tablet, coated, Tablet, Tablet - Oral, Tablet, effervescent, Tablet, effervescent - Oral, Tablet, chewable, Tablet, chewable - Oral, Powder, Powder - Oral, Suppository, Suppository - Rectal, Rectal, Kit, Tablet, multilayer - Oral, Tablet, multilayer, Tablet, delayed release, Tablet, extended release - Oral, Tablet, extended release, Capsule, extended release, Capsule, extended release - Oral, Strip - Oral, Capsule, coated - Oral, Capsule, coated, Capsule, gelatin coated, Capsule, gelatin coated - Oral, Tablet, delayed release - Oral, Tablet, orally disintegrating - Oral, Tablet, orally disintegrating, Strip, Tablet, delayed release; Tablet, extended release - Oral, Tablet, delayed release; Tablet, extended release, Gum, chewing, Gum, chewing - Oral, Kit; Tablet; Tablet, delayed release, Kit; Tablet; Tablet, delayed release - Oral, Kit; Tablet, delayed release; Tablet, extended release - Oral, Kit; Tablet, delayed release; Tablet, extended release, Paste - Dental, Dental, Paste, Granule, effervescent, Granule, effervescent - Oral, Topical, Granule, Granule - Oral, Oral; Topical, Kit - Oral; Topical, Tablet, Delayed Release - Oral, Tablet, Delayed Release, Capsule, Delayed Release - Oral, Kit - Topical, Capsule, Delayed Release, Kit - Oral, Kit - Ophthalmic; Oral; Topical, Ophthalmic; Oral; Topical, Ophthalmic; Oral; Respiratory (inhalation); Topical, Kit - Ophthalmic; Oral; Respiratory (inhalation); Topical, Lozenge, Lozenge - Oral, Spray, Kit - Oral; Respiratory (inhalation); Topical, Oral; Respiratory (inhalation); Topical, Tablet, film coated - Topical, Spray - Oral, Irrigation; Oral; Respiratory (inhalation); Topical, Kit - Irrigation; Oral; Respiratory (inhalation); Topical, Kit - Irrigation; Ophthalmic; Oral; Respiratory (inhalation); Topical, Irrigation; Ophthalmic; Oral; Respiratory (inhalation); Topical

Atrial Fibrillation

, 25.0 mg, 500.0 mg, 325.0 mg, 250.0 mg, 81.0 mg, 400.0 mg, 162.0 mg, 300.0 mg, 600.0 mg, 325000.0 mg, 770.0 mg, 8.1 mg/mg, 3.25 mg/mg, 0.325 mg, 0.81 mg, 0.5 mg, 356.4 mg, 650.0 mg, 162.5 mg, 845.0 mg, 1000.0 mg, 520.0 mg, 385.0 mg, 80.0 mg, 975.0 mg, 330.0 mg, 350.0 mg, 375.0 mg, 8.33 %, 150.0 mg, 2.2 mg/mg, 227.0 mg, 75.0 mg, 100.0 mg, 200.0 mg, 262.5 mg, 230.0 mg, 421.0 mg, 210.0 mg, 742.0 mg, 410.0 mg, 260.0 mg, 360.0 mg, 850.0 mg, 425.0 mg, 180.0 mg, 0.162 mg, 6.0 mg, 60.0 mg/mL

, Capsule, Oral, Capsule - Oral, Tablet, film coated, Tablet, film coated - Oral, Tablet, coated - Oral, Tablet, coated, Tablet, Tablet - Oral, Tablet, effervescent, Tablet, effervescent - Oral, Tablet, chewable, Tablet, chewable - Oral, Powder, Powder - Oral, Suppository, Suppository - Rectal, Rectal, Kit, Tablet, multilayer - Oral, Tablet, multilayer, Tablet, delayed release, Tablet, extended release - Oral, Tablet, extended release, Capsule, extended release, Capsule, extended release - Oral, Strip - Oral, Capsule, coated - Oral, Capsule, coated, Capsule, gelatin coated, Capsule, gelatin coated - Oral, Tablet, delayed release - Oral, Tablet, orally disintegrating - Oral, Tablet, orally disintegrating, Strip, Tablet, delayed release; Tablet, extended release - Oral, Tablet, delayed release; Tablet, extended release, Gum, chewing, Gum, chewing - Oral, Kit; Tablet; Tablet, delayed release, Kit; Tablet; Tablet, delayed release - Oral, Kit; Tablet, delayed release; Tablet, extended release - Oral, Kit; Tablet, delayed release; Tablet, extended release, Paste - Dental, Dental, Paste, Granule, effervescent, Granule, effervescent - Oral, Topical, Granule, Granule - Oral, Oral; Topical, Kit - Oral; Topical, Tablet, Delayed Release - Oral, Tablet, Delayed Release, Capsule, Delayed Release - Oral, Kit - Topical, Capsule, Delayed Release, Kit - Oral, Kit - Ophthalmic; Oral; Topical, Ophthalmic; Oral; Topical, Ophthalmic; Oral; Respiratory (inhalation); Topical, Kit - Ophthalmic; Oral; Respiratory (inhalation); Topical, Lozenge, Lozenge - Oral, Spray, Kit - Oral; Respiratory (inhalation); Topical, Oral; Respiratory (inhalation); Topical, Tablet, film coated - Topical, Spray - Oral, Irrigation; Oral; Respiratory (inhalation); Topical, Kit - Irrigation; Oral; Respiratory (inhalation); Topical, Kit - Irrigation; Ophthalmic; Oral; Respiratory (inhalation); Topical, Irrigation; Ophthalmic; Oral; Respiratory (inhalation); Topical

Toothache

, 25.0 mg, 500.0 mg, 325.0 mg, 250.0 mg, 81.0 mg, 400.0 mg, 162.0 mg, 300.0 mg, 600.0 mg, 325000.0 mg, 770.0 mg, 8.1 mg/mg, 3.25 mg/mg, 0.325 mg, 0.81 mg, 0.5 mg, 356.4 mg, 650.0 mg, 162.5 mg, 845.0 mg, 1000.0 mg, 520.0 mg, 385.0 mg, 80.0 mg, 975.0 mg, 330.0 mg, 350.0 mg, 375.0 mg, 8.33 %, 150.0 mg, 2.2 mg/mg, 227.0 mg, 75.0 mg, 100.0 mg, 200.0 mg, 262.5 mg, 230.0 mg, 421.0 mg, 210.0 mg, 742.0 mg, 410.0 mg, 260.0 mg, 360.0 mg, 850.0 mg, 425.0 mg, 180.0 mg, 0.162 mg, 6.0 mg, 60.0 mg/mL

, Capsule, Oral, Capsule - Oral, Tablet, film coated, Tablet, film coated - Oral, Tablet, coated - Oral, Tablet, coated, Tablet, Tablet - Oral, Tablet, effervescent, Tablet, effervescent - Oral, Tablet, chewable, Tablet, chewable - Oral, Powder, Powder - Oral, Suppository, Suppository - Rectal, Rectal, Kit, Tablet, multilayer - Oral, Tablet, multilayer, Tablet, delayed release, Tablet, extended release - Oral, Tablet, extended release, Capsule, extended release, Capsule, extended release - Oral, Strip - Oral, Capsule, coated - Oral, Capsule, coated, Capsule, gelatin coated, Capsule, gelatin coated - Oral, Tablet, delayed release - Oral, Tablet, orally disintegrating - Oral, Tablet, orally disintegrating, Strip, Tablet, delayed release; Tablet, extended release - Oral, Tablet, delayed release; Tablet, extended release, Gum, chewing, Gum, chewing - Oral, Kit; Tablet; Tablet, delayed release, Kit; Tablet; Tablet, delayed release - Oral, Kit; Tablet, delayed release; Tablet, extended release - Oral, Kit; Tablet, delayed release; Tablet, extended release, Paste - Dental, Dental, Paste, Granule, effervescent, Granule, effervescent - Oral, Topical, Granule, Granule - Oral, Oral; Topical, Kit - Oral; Topical, Tablet, Delayed Release - Oral, Tablet, Delayed Release, Capsule, Delayed Release - Oral, Kit - Topical, Capsule, Delayed Release, Kit - Oral, Kit - Ophthalmic; Oral; Topical, Ophthalmic; Oral; Topical, Ophthalmic; Oral; Respiratory (inhalation); Topical, Kit - Ophthalmic; Oral; Respiratory (inhalation); Topical, Lozenge, Lozenge - Oral, Spray, Kit - Oral; Respiratory (inhalation); Topical, Oral; Respiratory (inhalation); Topical, Tablet, film coated - Topical, Spray - Oral, Irrigation; Oral; Respiratory (inhalation); Topical, Kit - Irrigation; Oral; Respiratory (inhalation); Topical, Kit - Irrigation; Ophthalmic; Oral; Respiratory (inhalation); Topical, Irrigation; Ophthalmic; Oral; Respiratory (inhalation); Topical

Migraine

, 25.0 mg, 500.0 mg, 325.0 mg, 250.0 mg, 81.0 mg, 400.0 mg, 162.0 mg, 300.0 mg, 600.0 mg, 325000.0 mg, 770.0 mg, 8.1 mg/mg, 3.25 mg/mg, 0.325 mg, 0.81 mg, 0.5 mg, 356.4 mg, 650.0 mg, 162.5 mg, 845.0 mg, 1000.0 mg, 520.0 mg, 385.0 mg, 80.0 mg, 975.0 mg, 330.0 mg, 350.0 mg, 375.0 mg, 8.33 %, 150.0 mg, 2.2 mg/mg, 227.0 mg, 75.0 mg, 100.0 mg, 200.0 mg, 262.5 mg, 230.0 mg, 421.0 mg, 210.0 mg, 742.0 mg, 410.0 mg, 260.0 mg, 360.0 mg, 850.0 mg, 425.0 mg, 180.0 mg, 0.162 mg, 6.0 mg, 60.0 mg/mL

, Capsule, Oral, Capsule - Oral, Tablet, film coated, Tablet, film coated - Oral, Tablet, coated - Oral, Tablet, coated, Tablet, Tablet - Oral, Tablet, effervescent, Tablet, effervescent - Oral, Tablet, chewable, Tablet, chewable - Oral, Powder, Powder - Oral, Suppository, Suppository - Rectal, Rectal, Kit, Tablet, multilayer - Oral, Tablet, multilayer, Tablet, delayed release, Tablet, extended release - Oral, Tablet, extended release, Capsule, extended release, Capsule, extended release - Oral, Strip - Oral, Capsule, coated - Oral, Capsule, coated, Capsule, gelatin coated, Capsule, gelatin coated - Oral, Tablet, delayed release - Oral, Tablet, orally disintegrating - Oral, Tablet, orally disintegrating, Strip, Tablet, delayed release; Tablet, extended release - Oral, Tablet, delayed release; Tablet, extended release, Gum, chewing, Gum, chewing - Oral, Kit; Tablet; Tablet, delayed release, Kit; Tablet; Tablet, delayed release - Oral, Kit; Tablet, delayed release; Tablet, extended release - Oral, Kit; Tablet, delayed release; Tablet, extended release, Paste - Dental, Dental, Paste, Granule, effervescent, Granule, effervescent - Oral, Topical, Granule, Granule - Oral, Oral; Topical, Kit - Oral; Topical, Tablet, Delayed Release - Oral, Tablet, Delayed Release, Capsule, Delayed Release - Oral, Kit - Topical, Capsule, Delayed Release, Kit - Oral, Kit - Ophthalmic; Oral; Topical, Ophthalmic; Oral; Topical, Ophthalmic; Oral; Respiratory (inhalation); Topical, Kit - Ophthalmic; Oral; Respiratory (inhalation); Topical, Lozenge, Lozenge - Oral, Spray, Kit - Oral; Respiratory (inhalation); Topical, Oral; Respiratory (inhalation); Topical, Tablet, film coated - Topical, Spray - Oral, Irrigation; Oral; Respiratory (inhalation); Topical, Kit - Irrigation; Oral; Respiratory (inhalation); Topical, Kit - Irrigation; Ophthalmic; Oral; Respiratory (inhalation); Topical, Irrigation; Ophthalmic; Oral; Respiratory (inhalation); Topical

Catarrh

, 25.0 mg, 500.0 mg, 325.0 mg, 250.0 mg, 81.0 mg, 400.0 mg, 162.0 mg, 300.0 mg, 600.0 mg, 325000.0 mg, 770.0 mg, 8.1 mg/mg, 3.25 mg/mg, 0.325 mg, 0.81 mg, 0.5 mg, 356.4 mg, 650.0 mg, 162.5 mg, 845.0 mg, 1000.0 mg, 520.0 mg, 385.0 mg, 80.0 mg, 975.0 mg, 330.0 mg, 350.0 mg, 375.0 mg, 8.33 %, 150.0 mg, 2.2 mg/mg, 227.0 mg, 75.0 mg, 100.0 mg, 200.0 mg, 262.5 mg, 230.0 mg, 421.0 mg, 210.0 mg, 742.0 mg, 410.0 mg, 260.0 mg, 360.0 mg, 850.0 mg, 425.0 mg, 180.0 mg, 0.162 mg, 6.0 mg, 60.0 mg/mL

, Capsule, Oral, Capsule - Oral, Tablet, film coated, Tablet, film coated - Oral, Tablet, coated - Oral, Tablet, coated, Tablet, Tablet - Oral, Tablet, effervescent, Tablet, effervescent - Oral, Tablet, chewable, Tablet, chewable - Oral, Powder, Powder - Oral, Suppository, Suppository - Rectal, Rectal, Kit, Tablet, multilayer - Oral, Tablet, multilayer, Tablet, delayed release, Tablet, extended release - Oral, Tablet, extended release, Capsule, extended release, Capsule, extended release - Oral, Strip - Oral, Capsule, coated - Oral, Capsule, coated, Capsule, gelatin coated, Capsule, gelatin coated - Oral, Tablet, delayed release - Oral, Tablet, orally disintegrating - Oral, Tablet, orally disintegrating, Strip, Tablet, delayed release; Tablet, extended release - Oral, Tablet, delayed release; Tablet, extended release, Gum, chewing, Gum, chewing - Oral, Kit; Tablet; Tablet, delayed release, Kit; Tablet; Tablet, delayed release - Oral, Kit; Tablet, delayed release; Tablet, extended release - Oral, Kit; Tablet, delayed release; Tablet, extended release, Paste - Dental, Dental, Paste, Granule, effervescent, Granule, effervescent - Oral, Topical, Granule, Granule - Oral, Oral; Topical, Kit - Oral; Topical, Tablet, Delayed Release - Oral, Tablet, Delayed Release, Capsule, Delayed Release - Oral, Kit - Topical, Capsule, Delayed Release, Kit - Oral, Kit - Ophthalmic; Oral; Topical, Ophthalmic; Oral; Topical, Ophthalmic; Oral; Respiratory (inhalation); Topical, Kit - Ophthalmic; Oral; Respiratory (inhalation); Topical, Lozenge, Lozenge - Oral, Spray, Kit - Oral; Respiratory (inhalation); Topical, Oral; Respiratory (inhalation); Topical, Tablet, film coated - Topical, Spray - Oral, Irrigation; Oral; Respiratory (inhalation); Topical, Kit - Irrigation; Oral; Respiratory (inhalation); Topical, Kit - Irrigation; Ophthalmic; Oral; Respiratory (inhalation); Topical, Irrigation; Ophthalmic; Oral; Respiratory (inhalation); Topical

Fever

, 25.0 mg, 500.0 mg, 325.0 mg, 250.0 mg, 81.0 mg, 400.0 mg, 162.0 mg, 300.0 mg, 600.0 mg, 325000.0 mg, 770.0 mg, 8.1 mg/mg, 3.25 mg/mg, 0.325 mg, 0.81 mg, 0.5 mg, 356.4 mg, 650.0 mg, 162.5 mg, 845.0 mg, 1000.0 mg, 520.0 mg, 385.0 mg, 80.0 mg, 975.0 mg, 330.0 mg, 350.0 mg, 375.0 mg, 8.33 %, 150.0 mg, 2.2 mg/mg, 227.0 mg, 75.0 mg, 100.0 mg, 200.0 mg, 262.5 mg, 230.0 mg, 421.0 mg, 210.0 mg, 742.0 mg, 410.0 mg, 260.0 mg, 360.0 mg, 850.0 mg, 425.0 mg, 180.0 mg, 0.162 mg, 6.0 mg, 60.0 mg/mL

, Capsule, Oral, Capsule - Oral, Tablet, film coated, Tablet, film coated - Oral, Tablet, coated - Oral, Tablet, coated, Tablet, Tablet - Oral, Tablet, effervescent, Tablet, effervescent - Oral, Tablet, chewable, Tablet, chewable - Oral, Powder, Powder - Oral, Suppository, Suppository - Rectal, Rectal, Kit, Tablet, multilayer - Oral, Tablet, multilayer, Tablet, delayed release, Tablet, extended release - Oral, Tablet, extended release, Capsule, extended release, Capsule, extended release - Oral, Strip - Oral, Capsule, coated - Oral, Capsule, coated, Capsule, gelatin coated, Capsule, gelatin coated - Oral, Tablet, delayed release - Oral, Tablet, orally disintegrating - Oral, Tablet, orally disintegrating, Strip, Tablet, delayed release; Tablet, extended release - Oral, Tablet, delayed release; Tablet, extended release, Gum, chewing, Gum, chewing - Oral, Kit; Tablet; Tablet, delayed release, Kit; Tablet; Tablet, delayed release - Oral, Kit; Tablet, delayed release; Tablet, extended release - Oral, Kit; Tablet, delayed release; Tablet, extended release, Paste - Dental, Dental, Paste, Granule, effervescent, Granule, effervescent - Oral, Topical, Granule, Granule - Oral, Oral; Topical, Kit - Oral; Topical, Tablet, Delayed Release - Oral, Tablet, Delayed Release, Capsule, Delayed Release - Oral, Kit - Topical, Capsule, Delayed Release, Kit - Oral, Kit - Ophthalmic; Oral; Topical, Ophthalmic; Oral; Topical, Ophthalmic; Oral; Respiratory (inhalation); Topical, Kit - Ophthalmic; Oral; Respiratory (inhalation); Topical, Lozenge, Lozenge - Oral, Spray, Kit - Oral; Respiratory (inhalation); Topical, Oral; Respiratory (inhalation); Topical, Tablet, film coated - Topical, Spray - Oral, Irrigation; Oral; Respiratory (inhalation); Topical, Kit - Irrigation; Oral; Respiratory (inhalation); Topical, Kit - Irrigation; Ophthalmic; Oral; Respiratory (inhalation); Topical, Irrigation; Ophthalmic; Oral; Respiratory (inhalation); Topical

Wounds and Injuries

, 25.0 mg, 500.0 mg, 325.0 mg, 250.0 mg, 81.0 mg, 400.0 mg, 162.0 mg, 300.0 mg, 600.0 mg, 325000.0 mg, 770.0 mg, 8.1 mg/mg, 3.25 mg/mg, 0.325 mg, 0.81 mg, 0.5 mg, 356.4 mg, 650.0 mg, 162.5 mg, 845.0 mg, 1000.0 mg, 520.0 mg, 385.0 mg, 80.0 mg, 975.0 mg, 330.0 mg, 350.0 mg, 375.0 mg, 8.33 %, 150.0 mg, 2.2 mg/mg, 227.0 mg, 75.0 mg, 100.0 mg, 200.0 mg, 262.5 mg, 230.0 mg, 421.0 mg, 210.0 mg, 742.0 mg, 410.0 mg, 260.0 mg, 360.0 mg, 850.0 mg, 425.0 mg, 180.0 mg, 0.162 mg, 6.0 mg, 60.0 mg/mL

, Capsule, Oral, Capsule - Oral, Tablet, film coated, Tablet, film coated - Oral, Tablet, coated - Oral, Tablet, coated, Tablet, Tablet - Oral, Tablet, effervescent, Tablet, effervescent - Oral, Tablet, chewable, Tablet, chewable - Oral, Powder, Powder - Oral, Suppository, Suppository - Rectal, Rectal, Kit, Tablet, multilayer - Oral, Tablet, multilayer, Tablet, delayed release, Tablet, extended release - Oral, Tablet, extended release, Capsule, extended release, Capsule, extended release - Oral, Strip - Oral, Capsule, coated - Oral, Capsule, coated, Capsule, gelatin coated, Capsule, gelatin coated - Oral, Tablet, delayed release - Oral, Tablet, orally disintegrating - Oral, Tablet, orally disintegrating, Strip, Tablet, delayed release; Tablet, extended release - Oral, Tablet, delayed release; Tablet, extended release, Gum, chewing, Gum, chewing - Oral, Kit; Tablet; Tablet, delayed release, Kit; Tablet; Tablet, delayed release - Oral, Kit; Tablet, delayed release; Tablet, extended release - Oral, Kit; Tablet, delayed release; Tablet, extended release, Paste - Dental, Dental, Paste, Granule, effervescent, Granule, effervescent - Oral, Topical, Granule, Granule - Oral, Oral; Topical, Kit - Oral; Topical, Tablet, Delayed Release - Oral, Tablet, Delayed Release, Capsule, Delayed Release - Oral, Kit - Topical, Capsule, Delayed Release, Kit - Oral, Kit - Ophthalmic; Oral; Topical, Ophthalmic; Oral; Topical, Ophthalmic; Oral; Respiratory (inhalation); Topical, Kit - Ophthalmic; Oral; Respiratory (inhalation); Topical, Lozenge, Lozenge - Oral, Spray, Kit - Oral; Respiratory (inhalation); Topical, Oral; Respiratory (inhalation); Topical, Tablet, film coated - Topical, Spray - Oral, Irrigation; Oral; Respiratory (inhalation); Topical, Kit - Irrigation; Oral; Respiratory (inhalation); Topical, Kit - Irrigation; Ophthalmic; Oral; Respiratory (inhalation); Topical, Irrigation; Ophthalmic; Oral; Respiratory (inhalation); Topical

Bursitis

, 25.0 mg, 500.0 mg, 325.0 mg, 250.0 mg, 81.0 mg, 400.0 mg, 162.0 mg, 300.0 mg, 600.0 mg, 325000.0 mg, 770.0 mg, 8.1 mg/mg, 3.25 mg/mg, 0.325 mg, 0.81 mg, 0.5 mg, 356.4 mg, 650.0 mg, 162.5 mg, 845.0 mg, 1000.0 mg, 520.0 mg, 385.0 mg, 80.0 mg, 975.0 mg, 330.0 mg, 350.0 mg, 375.0 mg, 8.33 %, 150.0 mg, 2.2 mg/mg, 227.0 mg, 75.0 mg, 100.0 mg, 200.0 mg, 262.5 mg, 230.0 mg, 421.0 mg, 210.0 mg, 742.0 mg, 410.0 mg, 260.0 mg, 360.0 mg, 850.0 mg, 425.0 mg, 180.0 mg, 0.162 mg, 6.0 mg, 60.0 mg/mL

, Capsule, Oral, Capsule - Oral, Tablet, film coated, Tablet, film coated - Oral, Tablet, coated - Oral, Tablet, coated, Tablet, Tablet - Oral, Tablet, effervescent, Tablet, effervescent - Oral, Tablet, chewable, Tablet, chewable - Oral, Powder, Powder - Oral, Suppository, Suppository - Rectal, Rectal, Kit, Tablet, multilayer - Oral, Tablet, multilayer, Tablet, delayed release, Tablet, extended release - Oral, Tablet, extended release, Capsule, extended release, Capsule, extended release - Oral, Strip - Oral, Capsule, coated - Oral, Capsule, coated, Capsule, gelatin coated, Capsule, gelatin coated - Oral, Tablet, delayed release - Oral, Tablet, orally disintegrating - Oral, Tablet, orally disintegrating, Strip, Tablet, delayed release; Tablet, extended release - Oral, Tablet, delayed release; Tablet, extended release, Gum, chewing, Gum, chewing - Oral, Kit; Tablet; Tablet, delayed release, Kit; Tablet; Tablet, delayed release - Oral, Kit; Tablet, delayed release; Tablet, extended release - Oral, Kit; Tablet, delayed release; Tablet, extended release, Paste - Dental, Dental, Paste, Granule, effervescent, Granule, effervescent - Oral, Topical, Granule, Granule - Oral, Oral; Topical, Kit - Oral; Topical, Tablet, Delayed Release - Oral, Tablet, Delayed Release, Capsule, Delayed Release - Oral, Kit - Topical, Capsule, Delayed Release, Kit - Oral, Kit - Ophthalmic; Oral; Topical, Ophthalmic; Oral; Topical, Ophthalmic; Oral; Respiratory (inhalation); Topical, Kit - Ophthalmic; Oral; Respiratory (inhalation); Topical, Lozenge, Lozenge - Oral, Spray, Kit - Oral; Respiratory (inhalation); Topical, Oral; Respiratory (inhalation); Topical, Tablet, film coated - Topical, Spray - Oral, Irrigation; Oral; Respiratory (inhalation); Topical, Kit - Irrigation; Oral; Respiratory (inhalation); Topical, Kit - Irrigation; Ophthalmic; Oral; Respiratory (inhalation); Topical, Irrigation; Ophthalmic; Oral; Respiratory (inhalation); Topical

Endarterectomy, Carotid

, 25.0 mg, 500.0 mg, 325.0 mg, 250.0 mg, 81.0 mg, 400.0 mg, 162.0 mg, 300.0 mg, 600.0 mg, 325000.0 mg, 770.0 mg, 8.1 mg/mg, 3.25 mg/mg, 0.325 mg, 0.81 mg, 0.5 mg, 356.4 mg, 650.0 mg, 162.5 mg, 845.0 mg, 1000.0 mg, 520.0 mg, 385.0 mg, 80.0 mg, 975.0 mg, 330.0 mg, 350.0 mg, 375.0 mg, 8.33 %, 150.0 mg, 2.2 mg/mg, 227.0 mg, 75.0 mg, 100.0 mg, 200.0 mg, 262.5 mg, 230.0 mg, 421.0 mg, 210.0 mg, 742.0 mg, 410.0 mg, 260.0 mg, 360.0 mg, 850.0 mg, 425.0 mg, 180.0 mg, 0.162 mg, 6.0 mg, 60.0 mg/mL

, Capsule, Oral, Capsule - Oral, Tablet, film coated, Tablet, film coated - Oral, Tablet, coated - Oral, Tablet, coated, Tablet, Tablet - Oral, Tablet, effervescent, Tablet, effervescent - Oral, Tablet, chewable, Tablet, chewable - Oral, Powder, Powder - Oral, Suppository, Suppository - Rectal, Rectal, Kit, Tablet, multilayer - Oral, Tablet, multilayer, Tablet, delayed release, Tablet, extended release - Oral, Tablet, extended release, Capsule, extended release, Capsule, extended release - Oral, Strip - Oral, Capsule, coated - Oral, Capsule, coated, Capsule, gelatin coated, Capsule, gelatin coated - Oral, Tablet, delayed release - Oral, Tablet, orally disintegrating - Oral, Tablet, orally disintegrating, Strip, Tablet, delayed release; Tablet, extended release - Oral, Tablet, delayed release; Tablet, extended release, Gum, chewing, Gum, chewing - Oral, Kit; Tablet; Tablet, delayed release, Kit; Tablet; Tablet, delayed release - Oral, Kit; Tablet, delayed release; Tablet, extended release - Oral, Kit; Tablet, delayed release; Tablet, extended release, Paste - Dental, Dental, Paste, Granule, effervescent, Granule, effervescent - Oral, Topical, Granule, Granule - Oral, Oral; Topical, Kit - Oral; Topical, Tablet, Delayed Release - Oral, Tablet, Delayed Release, Capsule, Delayed Release - Oral, Kit - Topical, Capsule, Delayed Release, Kit - Oral, Kit - Ophthalmic; Oral; Topical, Ophthalmic; Oral; Topical, Ophthalmic; Oral; Respiratory (inhalation); Topical, Kit - Ophthalmic; Oral; Respiratory (inhalation); Topical, Lozenge, Lozenge - Oral, Spray, Kit - Oral; Respiratory (inhalation); Topical, Oral; Respiratory (inhalation); Topical, Tablet, film coated - Topical, Spray - Oral, Irrigation; Oral; Respiratory (inhalation); Topical, Kit - Irrigation; Oral; Respiratory (inhalation); Topical, Kit - Irrigation; Ophthalmic; Oral; Respiratory (inhalation); Topical, Irrigation; Ophthalmic; Oral; Respiratory (inhalation); Topical

Warnings

Robaxisal has nineteen counterindications and should not be employed simultaneously with the conditions given in the following table.

Robaxisal Contraindications

Condition

Risk Level

Notes

Severe Hypersensitivity Reactions

Do Not Combine

Acetylsalicylic Acid may interact with Pulse Frequency

Liver diseases

Do Not Combine

Third trimester of pregnancy

Do Not Combine

Asthma

Do Not Combine

Hemorrhagic Disorders

Do Not Combine

Nasal Polyps

Do Not Combine

Stomach Ulcer

Do Not Combine

Liver Failure

Do Not Combine

NSAID use

Do Not Combine

Pulse Frequency

Do Not Combine

Chronic Kidney Disease (CKD)

Do Not Combine

Asthma

Do Not Combine

Congestive Heart Failure

Do Not Combine

Allergic Rhinitis

Do Not Combine

Acute Coryza

Do Not Combine

Severe Hypersensitivity Reactions

Do Not Combine

Acetylsalicylic Acid may interact with Pulse Frequency

Severe Hypersensitivity Reactions

Do Not Combine

Acetylsalicylic Acid may interact with Pulse Frequency

Severe Hypersensitivity Reactions

Do Not Combine

Acetylsalicylic Acid may interact with Pulse Frequency

Severe Hypersensitivity Reactions

Do Not Combine

Acetylsalicylic Acid may interact with Pulse Frequency

There are 20 known major drug interactions with Robaxisal.

Common Robaxisal Drug Interactions

Drug Name

Risk Level

Description

Abrocitinib

Major

The risk or severity of bleeding and thrombocytopenia can be increased when Acetylsalicylic acid is combined with Abrocitinib.

Axitinib

Major

The metabolism of Axitinib can be increased when combined with Acetylsalicylic acid.

Cyclophosphamide

Major

The metabolism of Cyclophosphamide can be increased when combined with Acetylsalicylic acid.

Macimorelin

Major

The therapeutic efficacy of Macimorelin can be decreased when used in combination with Acetylsalicylic acid.

Methotrexate

Major

The risk or severity of adverse effects can be increased when Acetylsalicylic acid is combined with Methotrexate.

Robaxisal Toxicity & Overdose Risk

Acetylsalicylic acid (ASA) can be toxic in high doses, with an acute oral lethal dose of over 1.0 g/kg in humans, cats, and dogs, and 0.92-1.48 g/kg in rats. Signs of ASA poisoning include gastrointestinal distress, liver and kidney damage, respiratory depression, shock, and death. Long-term use of ASA can lead to dehydration, acid-base imbalance, kidney damage, and increased risk of gastrointestinal bleeding. Pregnant women should avoid ASA unless absolutely necessary, as it is teratogenic in animals and may have adverse effects on the fetus

image of a doctor in a lab doing drug, clinical research

Robaxisal Novel Uses: Which Conditions Have a Clinical Trial Featuring Robaxisal?

876 active clinical trials are presently investigating the use of Robaxisal to alleviate Chronic Stable Angina Pectoris, Acute Chest Syndrome and Generalized Anxiety Disorder.

Condition

Clinical Trials

Trial Phases

Chronic Pain

128 Actively Recruiting

Not Applicable, Phase 2, Phase 4, Phase 3, Early Phase 1, Phase 1

dental procedures

0 Actively Recruiting

Mortality

4 Actively Recruiting

Not Applicable, Phase 3, Phase 2

Atrial Fibrillation

103 Actively Recruiting

Not Applicable, Phase 4, Phase 1, Phase 3, Phase 2, Early Phase 1

Inflammation

61 Actively Recruiting

Not Applicable, Phase 2, Early Phase 1, Phase 3, Phase 1

Migraine

52 Actively Recruiting

Phase 4, Phase 1, Not Applicable, Phase 3, Phase 2, Early Phase 1

Generalized Anxiety Disorder

198 Actively Recruiting

Not Applicable, Early Phase 1, Phase 2, Phase 4, Phase 1, Phase 3

Back

4 Actively Recruiting

Not Applicable, Phase 3, Early Phase 1, Phase 1

Stroke

0 Actively Recruiting

Cardiovascular system

0 Actively Recruiting

Inflammation

0 Actively Recruiting

Toothache

1 Actively Recruiting

Not Applicable

Stroke

5 Actively Recruiting

Not Applicable, Phase 2, Phase 3

Lupus

63 Actively Recruiting

Phase 2, Phase 1, Phase 3, Not Applicable, Phase 4, Early Phase 1

Cardiovascular Mortality

0 Actively Recruiting

Stroke

0 Actively Recruiting

Transient Ischemic Attack

0 Actively Recruiting

Heart Valve Prosthesis

0 Actively Recruiting

Myocardial Infarction

0 Actively Recruiting

Hypercholesterolemia

4 Actively Recruiting

Phase 1, Phase 3

Robaxisal Reviews: What are patients saying about Robaxisal?

4.3

Patient Review

9/24/2013

Robaxisal for Sudden Uncontrolled Muscle Contraction with Pain

I didn't realize how much this drug was helping me until I ran out and had to go without it. I wish it came in a stronger strength than 750mg. My doctor says it has fewer side effects than soma, but I feel like soma works better for me.

4

Patient Review

3/5/2008

Robaxisal for Sudden Uncontrolled Muscle Contraction with Pain

4

Patient Review

10/16/2012

Robaxisal for Sudden Uncontrolled Muscle Contraction with Pain

I was in a car accident in 1996 and had some pretty severe injuries. I've been using this medication since then and it's helped, but I wish it were stronger.

3

Patient Review

11/25/2010

Robaxisal for Muscle Spasm

Patient Q&A Section about robaxisal

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is Robaxisal an anti-inflammatory?

"Methocarbamol belongs to the group of medications called muscle relaxants. Codeine belongs to the group of medications called opioids.

The combination product of acetylsalicylic acid, methocarbamol, and codeine contains three different types of medication. Acetylsalicylic acid is a pain reliever, anti-inflammatory, and fever reducer. Methocarbamol is a muscle relaxant. Codeine is an opioid."

Answered by AI

Is there codeine in Robaxisal?

"Each tablet contains methocarbamol 400mg, ASA 325mg, and codeine phosphate 32.4mg."

Answered by AI

Is Robaxisal a narcotic?

"This medication contains a narcotic pain reliever and a muscle relaxant which is typically used for muscle pain. Its effects can be felt within 1 hour."

Answered by AI

What is Robaxisal used for?

"Robaxisal compuesto is a medication that contains both methocarbamol and paracetamol. It is available as tablets and is used to treat painful muscle spasms associated with short-term muscle disorders, such as spasms in the lower back."

Answered by AI

Clinical Trials for Robaxisal

Image of UCLA Center for Clinical AIDS Research and Education (CARE) in Los Angeles, United States.

Eplerenone + Statins for Heart Disease in HIV

40 - 80
All Sexes
Los Angeles, CA

HIV has transitioned to a chronic disease in which well-treated persons remain at higher risk for heart disease when compared to the general population. Statin medications have been shown to reduce the number of events related to heart disease, but there are still individuals who will have complications from heart disease despite statin use. This study is being conducted to determine whether adding on another medication to statins called eplerenone, which has been shown to reduce inflammation in the heart vasculature among persons with HIV, can further decrease the risk of heart disease in HIV through its anti-inflammatory and blood pressure-lowering potential.

Phase 2 & 3
Waitlist Available

UCLA Center for Clinical AIDS Research and Education (CARE) (+1 Sites)

Image of Northwell health physician partners in Bay Shore, United States.

Lidocaine Injection vs Saline for Pain Management

18+
Female
Bay Shore, NY

We are doing this study to find the best way to manage pain during a procedure called urethral bulking. This procedure treats urine leakage that happens with coughing, laughing, sneezing, or physical activity. It works by injecting a gel-like substance around the urethra (the tube that urine comes out of) to help it stay closed when it should. We use a numbing gel (called lidocaine jelly) inside the urethra to help with pain during the procedure. In this study, we will also be administering lidocaine (numbing medication) injected around the urethra or a saline placebo (medical grade saltwater) injection, which has no numbing effect. A placebo is something that looks like a real treatment but doesn't have any medical effect. Both the lidocaine and the saline would be injected around the urethra using a small needle, and we'll compare how well they work at reducing pain.

Phase 4
Recruiting

Northwell health physician partners (+2 Sites)

Image of Endeavor Health/NorthShore in Skokie, United States.

Tranexamic Acid for Anterior Cruciate Ligament Injury

14 - 25
All Sexes
Skokie, IL

The goal of this clinical trial is to learn whether taking oral tranexamic acid (TXA) for one week after anterior cruciate ligament (ACL) reconstruction improves recovery in adolescents and young adults aged 14 to 25 years. All participants receive standard intravenous TXA during surgery. The main questions it aims to answer are: * Does oral TXA lower knee pain at 2 weeks after surgery? * Does oral TXA reduce the amount of opioid pain medicine used in the first 2 weeks? * Does oral TXA improve knee range of motion at 2 weeks? Researchers will compare oral TXA to a placebo (a look-alike capsule with no active drug) to see if oral TXA improves pain, opioid use, motion, strength, knee function, and return to sport. Participants will: * Take 3 capsules (oral TXA or placebo) once a day for the first 8 days after surgery (day of surgery through day 7) * Keep a home diary for 2 weeks recording pain scores, opioid pills taken and any side effects * Return for study visits at 2 weeks, 6 weeks, 12 weeks, 6 months, 9 months and 1 year for pain, motion, strength and function testing * Complete a survey at 2 years

Phase 3
Waitlist Available

Endeavor Health/NorthShore (+5 Sites)

Have you considered Robaxisal clinical trials?

We made a collection of clinical trials featuring Robaxisal, we think they might fit your search criteria.
Go to Trials
Image of IUCPQ-ULaval in Québec, Canada.

Mobile Healthcare for Cardiovascular Health

35 - 65
All Sexes
Québec, Canada

Indigenous people living in Canada face significant healthcare inequities, particularly in basic, primary, and secondary prevention, leading to higher rates of cardiovascular disease and mortality. This program aims to develop a comprehensive understanding of the contextual and individual determinants influencing Indigenous health, and to address health disparities by using tailored community-led participatory research and care initiatives. The investigator and research team use a Mobile Healthcare Unit travelling to Indigenous communities, providing customized, impactful, and sustainable preventive care that adapts dynamically to the evolving needs of each community. The initiative places a strong emphasis on equity and inclusivity, aiming to generate original data in Indigenous and remote underrepresented/underserved populations. This proposal will improve opportunities of identifying facilitators and barriers to preventive care in Indigenous and remote communities. This focus is vital for reducing health disparities and aligns with the Truth and Reconciliation Calls to Action. To maximize knowledge mobilization and ensure culturally appropriate initiatives align with community needs and priorities, this research program collaborates with the Indigenous University Hub at Laval University, local community members and leaders, and Indigenous peoples with lived experience. Existing national and international collaborations with Indigenous communities further enhance the initiative's potential impact and foster knowledge mobilization on a global scale. The ultimate goal is to empower Indigenous peoples and communities to advocate for systemic changes to fight inequities in healthcare in accordance with appropriated truth and reconciliation efforts.

Recruiting
Has No Placebo

IUCPQ-ULaval

Image of Weill Cornell Medicine, Starr Facility in New York, United States.

Transcendental Meditation for Burnout

18+
All Sexes
New York, NY

The goal of this study is to learn if a meditation intervention called Transcendental Meditation or TM can be used in a small department at Weill Cornell Medicine to help reduce employees' levels of burnout, anxiety, insomnia, and depression as well as to determine the feasibility and acceptability of the meditation practice by Weill Cornell employees. The main question the study aims to answer is whether: • Levels of burnout, anxiety, insomnia, and depression will be decreased, and overall mental well-being will improve over a 3.5-month period before and after TM intervention. Participants will attend 9 sessions total (8 group sessions and 1 individual session) with a certified TM instructor from The David Lynch Foundation Institute for Mental Health and Resilience where they will gain experience in proper TM techniques. Also, participants will conduct 2 of their own TM sessions at home daily during the course of this study.

Waitlist Available
Has No Placebo

Weill Cornell Medicine, Starr Facility

Joseph Osborne, MD, PhD

Have you considered Robaxisal clinical trials?

We made a collection of clinical trials featuring Robaxisal, we think they might fit your search criteria.
Go to Trials
Image of Texas Tech University Health Sciences Center/ University Medical Center Lubbock in Lubbock, United States.

PSP Monitoring for Sepsis in Burns

18 - 89
All Sexes
Lubbock, TX

The goal of this clinical trial is to learn if using pancreatic stone protein (PSP) test results helps doctors find and treat sepsis earlier in adults with serious burn injuries. The study will also look at whether using PSP is safe and practical in the burn intensive care unit. The main questions it aims to answer are: * Does seeing PSP test results help doctors start the right antibiotics sooner? * Does using PSP reduce unnecessary antibiotic use? * Does using PSP improve recovery and other health outcomes? Researchers will compare two groups of patients. One group will receive standard care, and their PSP test results will be hidden from their care team. The other group will receive standard care, but their care team will be able to see the PSP test results and use them to help make treatment decisions. Participants will: * Be randomly assigned to one of the two study groups. * Have a small blood sample taken within 24 hours after being admitted to the burn ICU and then once each weekday while they are in the ICU. * Receive the usual care for burn injuries and sepsis throughout the study.

Waitlist Available
Has No Placebo

Texas Tech University Health Sciences Center/ University Medical Center Lubbock

Brian Schneider, MD

Abionic SA

Image of Wahwala Iyohlogya/Peaceful Means in Pine Ridge, United States.

Lakota Family Acceptance Program for Relationship or Family Issues

Any Age
All Sexes
Pine Ridge, SD

Although research documents the concerning rates of mental and behavioral health problems (e.g., substance use/initiation) among Indigenous LGBTQ2S+ youth, there is very little known about how to prevent these deleterious issues that devastate Indigenous communities. The study will include \~40 families (Lakota LGBTQ2S+ youth and caregivers) in Rapid City, SD (20 families (10 FAP; 10 wait-list control) and on the nearby Pine Ridge Indian Reservation (10 FAP; 10 wait-list control). Following the baseline survey, families will be randomly assigned to the treatment or wait-list control. Participants will complete an immediate post-test and 6-month follow-up survey to test the hypotheses that FAP will lead to changes in targets, specifically increases in caregiver accepting behaviors, youth and caregiver connection to Lakota culture, family bonding, and youth future orientation and decreases in caregiver rejecting behaviors, caregiver harsh parenting, and youth internalized homo/bi/transphobia compared to the control condition. The researchers will also examine the hypotheses that there will be reductions in deleterious primary outcomes (depressive symptoms, anxiety symptoms, suicidality) and secondary outcomes (alcohol and drug use/initiation and dating and sexual violence victimization and perpetration) among youth in the treatment conditions compared to the control condition. Additionally, the researchers will assess the acceptability and feasibility of the FAP via program observations, post-session surveys, and exit interviews.

Waitlist Available
Has No Placebo

Wahwala Iyohlogya/Peaceful Means (+1 Sites)

Katie Edwards, PhD

Image of Northwestern Medicine Rheumatology in Chicago, United States.

Patient-Reported Outcomes Dashboard for Inflammatory Arthritis

18+
All Sexes
Chicago, IL

The goal of this clinical trial is to learn whether showing patient-reported symptoms and personal treatment goals to rheumatology clinicians on a dashboard in the electronic health record improves shared decision-making for adults with rheumatoid arthritis or psoriatic arthritis. The main questions it aims to answer are: * Do patients whose clinicians use the dashboard report more shared decision-making during their rheumatology visits than patients who receive usual care? * Do patients in the dashboard group report greater progress toward their personal goals and more confidence in managing their symptoms after 6 months? Researchers will compare the dashboard group to a usual care group to see if the dashboard improves shared decision-making, goal attainment, and self-efficacy. Participants will: * Complete a routine symptom questionnaire before their rheumatology visits, as all clinic patients do * Choose personal treatment goals and rate their progress toward those goals 6 months later * Complete short surveys before and after two rheumatology visits about 6 months apart Participants in the dashboard group will also complete questionnaires in the patient portal about pain, fatigue, physical function, sleep, and morning stiffness before each visit. Their answers and goals will be shown to their clinician on a dashboard to guide the conversation during the visit.

Waitlist Available
Has No Placebo

Northwestern Medicine Rheumatology

Image of Northwestern Memorial Hospital in Chicago, United States.

Psychological Prehabilitation for Gastrointestinal Disease

18+
All Sexes
Chicago, IL

The goal of this clinical trial is to learn if a psychological program before surgery can help adults who have lasting stress from past medical experiences. The program is called PREPARE-GI. It is for adults having planned, complex surgery on the digestive system, also called gastrointestinal (GI) surgery. Many people who need complex GI surgery have been through a lot. They may have had many surgeries, hospital stays, or emergency visits. These experiences can leave lasting stress, worry, and low mood. These feelings can make recovery from surgery harder. The main questions this study aims to answer are: * Can researchers sign up enough participants, and will participants attend the program sessions and finish the surveys? * Does the program lower stress, worry (anxiety), and low mood (depression)? * Does the program lower pain and improve quality of life after surgery? * Does the program shorten hospital stays or lower return visits to the hospital or emergency room? Researchers will compare two groups. One group will take part in the PREPARE-GI program. The other group will get usual surgical care. Participants will be placed in a group by chance, like flipping a coin. Adults may be able to join if they: Are 18 or older Have complex GI surgery planned at Northwestern Memorial Hospital at least 8 weeks away Score high on a short survey about stress from past experiences Can complete the study in English All participants will: Answer survey questions about stress, worry, mood, body symptoms, pain, and quality of life. They will do this before surgery, then 1 month and 3 months after surgery. The surveys will take about 20 to 30 minutes to complete. Rate their pain on a scale from 0 to 10 after surgery. Allow researchers to review their medical records for information about their surgery and recovery. Participants in the program group will also meet one-on-one with a licensed psychologist for 8 sessions. Each session lasts about 1 hour and will take place either in person or by secure video from home. In the sessions, participants will learn skills to manage stress, handle difficult feelings, and prepare for surgery and recovery. Participants will be in the study for about 5 months. Participants in the program group will spend about 9 to 10 hours on the study. Participants in the usual care group will spend about 1 to 1.5 hours. This is a small study with 20 participants. The results will help researchers plan a larger study in the future.

Recruiting
Has No Placebo

Northwestern Memorial Hospital

Michael Rosen, MD

Have you considered Robaxisal clinical trials?

We made a collection of clinical trials featuring Robaxisal, we think they might fit your search criteria.
Go to Trials